261 related articles for article (PubMed ID: 20878444)
1. Treatment of bevacizumab-induced hypertension by amlodipine.
Mir O; Coriat R; Ropert S; Cabanes L; Blanchet B; Camps S; Billemont B; Knebelmann B; Goldwasser F
Invest New Drugs; 2012 Apr; 30(2):702-7. PubMed ID: 20878444
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of aliskiren/amlodipine single-pill combinations in patients who did not respond fully to amlodipine monotherapy¥.
Pfeiffer D; Rennie N; Papst CC; Zhang J
Curr Vasc Pharmacol; 2012 Nov; 10(6):773-80. PubMed ID: 22303911
[TBL] [Abstract][Full Text] [Related]
3. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive efficacy and tolerability of aliskiren/amlodipine single- pill combinations in patients with an inadequate response to aliskiren monotherapy.
Glorioso N; Thomas M; Troffa C; Argiolas G; Patel S; Baek I; Zhang J
Curr Vasc Pharmacol; 2012 Nov; 10(6):748-55. PubMed ID: 22303910
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension.
White WB; Saunders E; Noveck RJ; Ferdinand K
Am J Hypertens; 2003 Sep; 16(9 Pt 1):739-45. PubMed ID: 12944032
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab-induced hypertension: pathogenesis and management.
Syrigos KN; Karapanagiotou E; Boura P; Manegold C; Harrington K
BioDrugs; 2011 Jun; 25(3):159-69. PubMed ID: 21627340
[TBL] [Abstract][Full Text] [Related]
7. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
Bobrie G;
Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
[TBL] [Abstract][Full Text] [Related]
8. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
Bobrie G;
Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group.
Zidek W; Spiecker C; Knaup G; Steindl L; Breuer HW
Clin Ther; 1995; 17(4):686-700. PubMed ID: 8565032
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
Payeras AC; Sladek K; Lembo G; Alberici M
Clin Drug Investig; 2007; 27(9):623-32. PubMed ID: 17705571
[TBL] [Abstract][Full Text] [Related]
11. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
[TBL] [Abstract][Full Text] [Related]
12. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
[TBL] [Abstract][Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Punzi H; Neutel JM; Kereiakes DJ; Shojaee A; Waverczak WF; Dubiel R; Maa JF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
[TBL] [Abstract][Full Text] [Related]
16. Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial.
Oh GC; Lee HY; Kang HJ; Zo JH; Choi DJ; Oh BH
Clin Ther; 2012 Sep; 34(9):1940-7. PubMed ID: 22925988
[TBL] [Abstract][Full Text] [Related]
17. Amlodipine Compared with Benidipine in the Management of Hypertension: A Systematic Review and Meta-Analysis.
Sofy AA; Abdelsattar AT; Mohammed OM; Shareef MA; Alamodi AA; Nso N; Payton M; Masoud AT
High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):527-537. PubMed ID: 33001356
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension.
Dingemanse J; Otasevic P; Shakeri-Nejad K; Klainman E; Putnikovic B; Kracker H; Mueller MS; Zimlichman R
J Hum Hypertens; 2015 Apr; 29(4):229-35. PubMed ID: 25231512
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.
Bramlage P; Wolf WP; Stuhr T; Fronk EM; Erdlenbruch W; Ketelhut R; Schmieder RE
Vasc Health Risk Manag; 2010 Sep; 6():803-11. PubMed ID: 20859549
[TBL] [Abstract][Full Text] [Related]
20. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
Chrysant SG
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
